Validated Absorption Factor Spectrophotometric and Reversed-Phase High-Performance Liquid Chromatographic Methods for the Determination of Ramipril and Olmesartan Medoxomil in Pharmaceutical Formulations
 
More details
Hide details
1
A. R. College of Pharmacy and Institute of Science and Technology for Advance Studies and Research (I.S.T.A.R) Vallabh Vidya nagar- 388120; Gujarat, India
2
Analytical Development Laboratory, Cadila Healthcare Limited, Moraiya Ahmedabad, Gujarat,India. cTorrent Research Center, Bhatt, Ahmedabad-382 210; Gujarat, India
3
Torrent Research Center, Bhatt, Ahmedabad-382 210; Gujarat, India
CORRESPONDING AUTHOR
Chintan V. Patela   

A. R. College of Pharmacy and Institute of Science and Technology for Advance Studies and Research (I.S.T.A.R) Vallabh Vidya nagar- 388120; Gujarat India
Publish date: 2017-10-04
 
Eurasian J Anal Chem 2007;2(3):159–171
KEYWORDS
ABSTRACT
Two simple and sensitive spectrophotometric and liquid chromatographic (LC) methods are described for the determination of ramipril and olmesartan medoxomil. The first method was based on the absorption factor. Ramipril and olmesartan medoxomil exhibit λmax at 210 nm and 256 nm respectively. Olmesartan medoxomil has some interference at 210nm, while ramipril do not show any absorption at 256 nm.Quantitative estimation of ramipril was carried out by subtracting the absorption due to olmesartan medoxomil at 210 nm using experimentally calculated absorption factor. Beer’s law was obeyed for ramipril and olmesartan medoxomil at 2-6 µg mL-1 and 8-24 µg mL-1 respectively. The second method, high-performance liquid chromatographic method was developed for the determination of ramipril and olmeasartan medoxomil using sodium perchlorate: acetonitrile (60:40, v/v) as the mobile phase and measuring the response at λmax 210 nm. The analysis was performed on a Phenomenex C8 (250 X 4.0 mm), 5 µm column. The calibration curve was obtained for ramipril and olmesartan medoxomil at 1-6 µg mL-1 and 4-24 µg mL-1 respectively. The mean recovery was 99.80 ± 0.20% and 99.86 ± 0.20% for ramipril and olmesartan medoxomil respectively. The methods were validated according to the ICH guidelines.
 
REFERENCES (17)
1.
Kukushkin S K, Lebedev A V, Manoshkina E M, Shamarin V M (1998) Ramipril effects on 24-hour profile of blood pressure in patients with mild and moderate hypertension. J Pharm Biomed Anal 70(9): 69-71.
 
2.
Reinhard H A., Becker M D, Bernard M D, SchÜlkens M D (1987) Ramipril: Review of pharmacology. J Clin Pharmacol 59(10): 3-11.
 
3.
Strawn W B, Chappell M C, Dean R H (2000) Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia, J.Pharm.Biomed Anal., 101(7):1586.
 
4.
Páchler K, Laeis P, Stumpe K O (2001) A comparison of the efficacy and safety of the oral angiotensin II antagonist Olmesartan medoxomil with those of atenolol inpatients with moderate to severe hypertension under continuous treatment with hydrochlorothiazide. J Pharm Biomed Anal 19 (2): 153.
 
6.
Ball K, A (2001) Multicentre, double-blind, efficacy, tolerability and safety study of the oral angiotensin II antagonist Olmesartan medoxomil versus losartan in patients with mild to moderate essential hypertension. J Pharm Biomed Anal 19 (2): 153.
 
7.
Zhimeng Z, Andre V, Len N.(2002) Liquid chromatography–mass spectrometry method for determination of Ramipril and its active metabolite ramiprilat in human plasma. J Chromatogr B 779(2): 297-306.
 
8.
Magda M, Ayad A, Shalaby E, Abdellate F (2002) Spectrophotometric and AAS determination of Ramipril and Enalapril through ternary complex formation J Pharm Biomed Anal 28 (2): 311.
 
9.
Hillaert S, Grauwe K, Bossche W (2001) Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis. J Chromatogr A 924 (1):439.
 
10.
Belal F, Al-Zaagi A, Gadkariem E, Abounassif M (2001) A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms J Pharm Biomed Anal 24(3):335.
 
11.
Barry L, Mark Williams, H, Anna I, Veysoglu T, Parente E (2000) Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J Pharm Biomed Anal 23 (4):637-651.
 
12.
Hisham E, Magda M, Elham A (1999) Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu (II). J Pharm Biomed Anal 18 (6):1027.
 
13.
Bonazzi D, Gotti R, Andrisano V, Cavrini V (1997) Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). J Pharm Biomed Anal 16(3):431-438.
 
14.
Zarapkar S S, Rane S H (2000) RP- HPLC determination of ramipril and hydrochlorothiazide in tablet Indian. J Pharma Sci 37(12):589-593.
 
15.
Daharwal S J, Garg G, Saudagar R B, Saraf S (2006) Methods of estimation of multicomponent formulations. Indian J Pharma Sci 19(8):102.
 
16.
Stenlake J B, Backett A H (1997) Practical pharmaceutical Chemistry, 4 th Edition, Part- 2, C. B. S. Publishers, p281.
 
17.
Tipre D N, Kasture A V (2000) Simultaneous estimation of Ciprofloxacin and Tinidazole in tablet dosage form using spectrophotometric and HPLC methods. Indian Drugs 37(3): 148-154.
 
eISSN:1306-3057